{"id":"W2600898566","doi":"10.1200/jco.2012.30.15_suppl.540","title":"BOLERO-2: Everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone receptor-positive breast cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Everolimus; Internal medicine; Dysgeusia; Letrozole; Aromatase inhibitor; Anastrozole; Breast cancer; Oncology; Clinical endpoint; Adverse effect; Placebo; Population; Progression-free survival; Cancer; Clinical trial; Aromatase; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001389797,0.0006092135,0.001544511,0.0003117598,0.0001869053,0.0006281015,0.0004723269,0.0004880478,0.002392707],"category_scores_gemma":[0.0009264002,0.000295493,0.001361516,0.000318146,0.000463398,0.0007737668,0.0004423559,0.001370471,0.0003300467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004856486,"about_ca_system_score_gemma":0.000722886,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004205189,"about_ca_topic_score_gemma":0.001890308,"domain_scores_codex":[0.9996303,0.000203722,0.00003659396,0.00005242222,0.0000304444,0.0000465459],"domain_scores_gemma":[0.9995141,0.0001158086,0.0001584348,0.00003010766,0.00001467155,0.0001668743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8893479,0.008719686,0.01051569,0.0007246949,0.002411562,0.000128609,0.0001604604,0.00093541,0.008971167,0.0001277043,0.0006800581,0.07727703],"study_design_scores_gemma":[0.4191447,0.5172964,0.04940923,0.0001403298,0.004133082,0.0004562475,0.000174331,0.002253088,0.003490841,0.0002733922,0.00317905,0.00004931229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947006,0.003597432,0.0001233859,0.000211372,0.00007112404,0.0002088174,0.0001673124,0.00001730724,0.0009026545],"genre_scores_gemma":[0.9961523,0.001795953,0.0004331898,0.00035673,0.0001044065,0.0002360956,0.0003048222,0.000005167266,0.000611274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002392707,"threshold_uncertainty_score":0.008004427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05317573863883323,"score_gpt":0.4219023762950248,"score_spread":0.3687266376561916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}